Singapore markets closed

Perrigo Company plc (PRGO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
31.27+0.04 (+0.13%)
At close: 04:00PM EDT
31.27 0.00 (0.00%)
After hours: 06:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close31.23
Open31.10
Bid0.00 x 800
Ask35.00 x 800
Day's range30.79 - 32.12
52-week range25.77 - 40.28
Volume1,072,039
Avg. volume1,999,253
Market cap4.238B
Beta (5Y monthly)0.65
PE ratio (TTM)N/A
EPS (TTM)-0.03
Earnings date07 May 2024
Forward dividend & yield1.10 (3.50%)
Ex-dividend date07 Mar 2024
1y target est40.50
  • PR Newswire

    Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million

    Perrigo Company plc (NYSE PRGO) ("Perrigo" or the "Company"), a leading provider of Consumer Self-Care Products, today announced that pharmaceutical company Esteve Healthcare, S.L. ("ESTEVE") has signed a binding offer to acquire Perrigo's HRA Pharma Rare Diseases business for a total consideration of up to €275 million, consisting of an upfront cash payment of €190 million and up to €85 million in potential earnout payments based on the Rare Diseases business achieving certain sales milestones.

  • PR Newswire

    Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024

    Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its first quarter 2024 financial results on Tuesday, May 7th, 2024, and host a conference call beginning at 8:30 A.M. (EDT).

  • Insider Monkey

    Here’s Why Perrigo Company PLC (PRGO) Stock Slumped in Q1

    Heartland Advisors, an investment management company, released its “Heartland Mid Cap Value Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The portfolio had a 5.7% gain in the first quarter compared to an 8.2% return in the Russell Midcap Value Index. The Strategy underperformed in Financials and Industrials due […]